Early research (Phase 1)WithdrawnNCT00045838What this trial is testingHIV-1 Vaccine Test in Uninfected Adult VolunteersWho this might be right forHealthy National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT00697840What this trial is testingSafety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-BWho this might be right forHepatitis B GlaxoSmithKline 150
Large-scale testing (Phase 3)UnknownNCT05771155What this trial is testingEfficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®Who this might be right forUlcerative Colitis Polpharma Biologics S.A. 750
Early research (Phase 1)UnknownNCT05125926What this trial is testingA Phase Ⅰ Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001Who this might be right forCOVID-19 Yantai Patronus Biotech Co., Ltd. 100
Early research (Phase 1)Study completedNCT00889616What this trial is testingPhase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and MaliWho this might be right forMalaria National Institute of Allergy and Infectious Diseases (NIAID) 154
Testing effectiveness (Phase 2)Looking for participantsNCT06655155What this trial is testingAssess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic SclerosisWho this might be right forSystemic Sclerosis (SSc) argenx 81
Early research (Phase 1)Study completedNCT03343626What this trial is testingSafety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy ParticipantsWho this might be right forVirus, ZikaZika Virus DiseaseFlavivirus Infections+1 more Takeda 271
Early research (Phase 1)Ended earlyNCT02014168What this trial is testingSafety and Immunogenicity of Co-administration of Candidate Influenza Vaccine MVA-NP+M1 and Viroflu® Seasonal Influenza VaccineWho this might be right forInfluenza University of Oxford 3
Large-scale testing (Phase 3)Study completedNCT00316706What this trial is testingHuman Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 VaccineWho this might be right forCervical Intraepithelial NeoplasiaPapillomavirus Infection GlaxoSmithKline 1,245
Large-scale testing (Phase 3)Study completedNCT01633749What this trial is testingAnnual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 SeasonWho this might be right forProphylaxis of Influenza Abbott Biologicals 120
Early research (Phase 1)Study completedNCT04529538What this trial is testingStudy of Novel Types 1 and 3 Oral Poliomyelitis VaccinesWho this might be right forPoliomyelitis PATH 226
Early research (Phase 1)Not Yet RecruitingNCT07606976What this trial is testingSSS68 Following a Single Subcutaneous Administration in Healthy Adult ParticipantsWho this might be right forHealthy Shenyang Sunshine Pharmaceutical Co., LTD. 50
Large-scale testing (Phase 3)Study completedNCT04381689What this trial is testingPhase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy InfantsWho this might be right forHealthy Il-Yang Pharm. Co., Ltd. 260
Large-scale testing (Phase 3)Study completedNCT02979535What this trial is testingImmunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®Who this might be right forDengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease Sanofi Pasteur, a Sanofi Company 480
Large-scale testing (Phase 3)Ended earlyNCT06643117What this trial is testingSimilar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC)Who this might be right forNon Small Cell Lung CancerNon-Squamous Non-Small Cell Lung Cancer Formycon AG 25
Large-scale testing (Phase 3)Study completedNCT05158140What this trial is testingSafety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)Who this might be right forPneumococcal Infection Merck Sharp & Dohme LLC 850
Large-scale testing (Phase 3)Study completedNCT07222384What this trial is testingLearn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19Who this might be right forCOVID-19SARS-COV-2 Infection BioNTech SE 344
Early research (Phase 1)UnknownNCT06167915What this trial is testingSafety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster VaccinationWho this might be right forSARS-CoV-2COVID-19 Vaccine Guangzhou Patronus Biotech Co., Ltd. 120
Large-scale testing (Phase 3)WithdrawnNCT05926440What this trial is testingImmunogenicity and Safety Study of SCB-2023 Vaccine as a Booster in AdultsWho this might be right forCOVID-19 Clover Biopharmaceuticals AUS Pty
Large-scale testing (Phase 3)Study completedNCT03893448What this trial is testingSafety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)Who this might be right forPneumococcal InfectionsPneumococcal Vaccines Merck Sharp & Dohme LLC 1,720